Article
- Author:
- Jeffrey M. Weinberg, MD
Publish date: August 12, 2016
For the last decade, we have considered the cardioprotective benefit of biologics, especially in patients with chronic inflammatory diseases. Due t...
Article
- Author:
- Jeffrey M. Weinberg, MD
Publish date: July 6, 2016
We are aware of the clinical importance of diagnosing psoriatic arthritis (PsA) as early as possible to initiate appropriate therapy. Because psori...
Article
- Author:
- Jeffrey M. Weinberg, MD
Publish date: May 20, 2016
Abdominal aortic aneurysm (AAA) is a complex multifactorial disease associated with high morbidity and mortality. When an AAA ruptures, often with ...
Article
- Author:
- Jeffrey M. Weinberg, MD
Publish date: April 25, 2016
According to a study by Ji et al published online on February 11 in the International Journal of Impotence Research, men with psoriasis may ...
Article
- Author:
- Jeffrey M. Weinberg, MD
Publish date: March 29, 2016
Biologic agents for the treatment of psoriasis are approved for patients 18 years and older. Although some biologics are approved for juvenile idio...
Article
- Author:
- Jeffrey M. Weinberg, MD
Publish date: February 17, 2016
The primary comorbidity of psoriasis is psoriatic arthritis (PsA). The true incidence of PsA has long been an issue of debate. To estimate the inci...
Article
- Author:
- Jeffrey M. Weinberg, MD
Publish date: February 11, 2016
The evaluation and treatment of psoriasis in older patients have long been issues of interest among clinicians. This population is at risk from com...
Article
- Author:
- Jeffrey M. Weinberg, MD
Publish date: January 22, 2016
One of the biggest burdens of modern clinical dermatology practice is the ability to obtain appropriate drug therapy for patients. In the current h...
Article
- Author:
- Jeffrey M. Weinberg, MD
Publish date: January 8, 2016
On October 14, 2015, the US Food and Drug Administration declined to approve tofacitinib citrate, an oral rheumatoid arthritis drug, for the...
Article
- Author:
- Jeffrey M. Weinberg, MD
Publish date: November 2, 2015
While psoriasis is a known risk factor for depression, depression can also exacerbate or trigger psoriasis. This relationship between depression an...
Article
- Author:
- Jeffrey M. Weinberg, MD
Publish date: October 1, 2015
With the advent of tumor necrosis factor (TNF) inhibitors, one of the major topics of discussion is the relationship of the drug class with new or ...
Article
- Author:
- Jeffrey M. Weinberg, MD
Publish date: August 18, 2015
We are all aware of the association of psoriasis with systemic comorbidities. Psoriasis, psoriatic arthritis (PsA), and uveitis are inflammatory di...
Article
- Author:
- Jeffrey M. Weinberg, MD
Publish date: August 13, 2015
Pregnant patients can experience improved severity of their psoriasis or worsening disease. Treating psoriasis during pregnancy requires special at...
Article
- Author:
- Jeffrey M. Weinberg, MD
Publish date: July 14, 2015
Of all the comorbidities associated with psoriasis, psoriatic arthritis (PsA) is the most common and one of the most problematic. Early recognition...
Article
- Author:
- Jeffrey M. Weinberg, MD
Publish date: July 13, 2015
The therapeutic armamentarium for patients with psoriasis and psoriatic arthritis (PsA) has been strengthened by research affording more individual...
